Notice: Undefined index: a44778c7821486d647f3ad4846699216 in /home/mafi01/domains/urhinula.si/public_html/components/com_rssfactory_pro/models/visitstory.php on line 39
ProQR Announces Clearance of IND to Start Clinical Trial of QR-1123 in Patients with Autosomal Dominant Retinitis Pigmentosa (adRP) - Nasdaq
ProQR Announces Clearance of IND to Start Clinical Trial of QR-1123 in Patients with Autosomal Dominant Retinitis Pigmentosa (adRP)  Nasdaq

LEIDEN, Netherlands and CAMBRIDGE, Mass., Aug. 12, 2019-- ProQR Therapeutics N.V., a company dedicated to changing lives through the creation of.